Evaluation of anti α-d-Glc<i>p</i>-(1→4)-α-d-Glc<i>p</i> (GAGA4) IgM antibodies as a biomarker for multiple sclerosis.

导出 OA

翻译打印收藏纠错

作者： Chriselle D,Braganza ^[1] ; Kristiana T,Santoso ^[2] ; Emma M,Dangerfield ^[1] ; Anne C,La Flamme ^[2] ; Mattie S M,Timmer ^[1] ; Bridget L,Stocker ^[2]

作者单位： School of Chemical and Physical Sciences, Victoria University of Wellington P. O. Box 600 Wellington 6140 New Zealand. ^[1] Centre for Biodiscovery, Victoria University of Wellington P. O. Box 600 Wellington 6140 New Zealand mattie.timmer@vuw.ac.nz bridget.stocker@vuw.ac.nz. ^[2] Malaghan Institute of Medical Research, Victoria University of Wellington P. O. Box 7060 Wellington 6242 New Zealand. ^[3]

DOI 10.1039/c8ra04897e

PMID 35542693

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

RSC advances

2018年8卷49期

28086-28093页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluation of anti α-d-Glc<i>p</i>-(1→4)-α-d-Glc<i>p</i> (GAGA4) IgM antibodies as a biomarker for multiple sclerosis.

RSC advances

相似文献

RSC advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of anti α-d-Glc<i>p</i>-(1→4)-α-d-Glc<i>p</i> (GAGA4) IgM antibodies as a biomarker for multiple sclerosis.

RSC advances

相似文献

RSC advances

相关期刊

检索历史清除